Four Decades for Justice
Cravath represented Mylan N.V. in connection with its €3 billion Reg. S senior floating and fixed rate debt offering. Mylan N.V. is a leading global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The notes were listed on the Irish Stock Exchange. The transaction closed on November 22, 2016.
The Cravath team included partner William V. Fogg and associates Benjamin S. Persina, Martin P. Pepeljugoski and Jin‑Kyu Baek.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.